Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells

Walter H. Newman, Manuel R Castresana, Jerry G. Webb, Zhongbiao Wang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background. Gene expression induced by tumor necrosis factor-α (TNF-α) is involved in the regulation of vascular smooth muscle cell (VSMC) proliferation and migration, two events critical to formation of stenotic vascular lesions. In some systems, elevating adenosine 3′,5′-cyclic monophosphate (cyclic AMP) inhibits TNF-α induced gene transcription. We recently demonstrated that interleukin-6 (IL-6) was chemotactic to VSMC. Therefore, we tested the hypothesis that elevating cyclic AMP would inhibit TNF-α-mediated IL-6 expression and VSMC migration. Materials and methods. VSMC were cultured from saphenous vein remaining after coronary artery bypass grafting. Migration of VSMC through a porous membrane was determined. Intracellular cyclic AMP was elevated by exposing the cells to forskolin or 8-Br-cyclic AMP and was measured by radioimmunoassay. IL-6 was measured by enzyme-linked immunosorbent assay. Results. TNF-α induced migration of VSMC in a concentration-dependent manner. Incubation of cells with forskolin significantly increased cyclic AMP. Co-incubation of cells with TNF-α in combination with 8-Br-cyclic AMP or forskolin inhibited migration by approximately 25 and 70%, respectively. Incubation with TNF-α increased release of IL-6 from VSMC 18-fold over basal. This stimulated release was inhibited by either 8-Br-cyclic AMP or forskolin. In cells stimulated with TNF-α, addition of an antibody to IL-6 reduced migration by 25%. Conclusions. These data show that IL-6 produced by VSMC contributes to cell migration induced by TNF-α. Further, elevating cyclic AMP inhibited TNF-α-induced release of IL-6, and migration of VSMC. These results are consistent with the notion that mechanisms that increase intracellular cyclic AMP, such as activation of β-adrenergic receptors on VSMC, act as a brake on cell migration.

Original languageEnglish (US)
Pages (from-to)57-61
Number of pages5
JournalJournal of Surgical Research
Volume109
Issue number1
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Vascular Smooth Muscle
Cyclic AMP
Smooth Muscle Myocytes
Interleukin-6
Tumor Necrosis Factor-alpha
Colforsin
8-Bromo Cyclic Adenosine Monophosphate
Cell Movement
Saphenous Vein
Coronary Artery Bypass
Adenosine
Adrenergic Receptors
Radioimmunoassay
Blood Vessels
Enzyme-Linked Immunosorbent Assay
Cell Proliferation
Gene Expression
Membranes
Antibodies

Keywords

  • Cyclic AMP
  • Interleukin-6
  • Smooth muscle cell migration, tumor necrosis factor-α

ASJC Scopus subject areas

  • Surgery

Cite this

Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells. / Newman, Walter H.; Castresana, Manuel R; Webb, Jerry G.; Wang, Zhongbiao.

In: Journal of Surgical Research, Vol. 109, No. 1, 01.01.2003, p. 57-61.

Research output: Contribution to journalArticle

@article{500e3f42eac743bc9febf21a10fedf3d,
title = "Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells",
abstract = "Background. Gene expression induced by tumor necrosis factor-α (TNF-α) is involved in the regulation of vascular smooth muscle cell (VSMC) proliferation and migration, two events critical to formation of stenotic vascular lesions. In some systems, elevating adenosine 3′,5′-cyclic monophosphate (cyclic AMP) inhibits TNF-α induced gene transcription. We recently demonstrated that interleukin-6 (IL-6) was chemotactic to VSMC. Therefore, we tested the hypothesis that elevating cyclic AMP would inhibit TNF-α-mediated IL-6 expression and VSMC migration. Materials and methods. VSMC were cultured from saphenous vein remaining after coronary artery bypass grafting. Migration of VSMC through a porous membrane was determined. Intracellular cyclic AMP was elevated by exposing the cells to forskolin or 8-Br-cyclic AMP and was measured by radioimmunoassay. IL-6 was measured by enzyme-linked immunosorbent assay. Results. TNF-α induced migration of VSMC in a concentration-dependent manner. Incubation of cells with forskolin significantly increased cyclic AMP. Co-incubation of cells with TNF-α in combination with 8-Br-cyclic AMP or forskolin inhibited migration by approximately 25 and 70{\%}, respectively. Incubation with TNF-α increased release of IL-6 from VSMC 18-fold over basal. This stimulated release was inhibited by either 8-Br-cyclic AMP or forskolin. In cells stimulated with TNF-α, addition of an antibody to IL-6 reduced migration by 25{\%}. Conclusions. These data show that IL-6 produced by VSMC contributes to cell migration induced by TNF-α. Further, elevating cyclic AMP inhibited TNF-α-induced release of IL-6, and migration of VSMC. These results are consistent with the notion that mechanisms that increase intracellular cyclic AMP, such as activation of β-adrenergic receptors on VSMC, act as a brake on cell migration.",
keywords = "Cyclic AMP, Interleukin-6, Smooth muscle cell migration, tumor necrosis factor-α",
author = "Newman, {Walter H.} and Castresana, {Manuel R} and Webb, {Jerry G.} and Zhongbiao Wang",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/S0022-4804(02)00038-0",
language = "English (US)",
volume = "109",
pages = "57--61",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells

AU - Newman, Walter H.

AU - Castresana, Manuel R

AU - Webb, Jerry G.

AU - Wang, Zhongbiao

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Background. Gene expression induced by tumor necrosis factor-α (TNF-α) is involved in the regulation of vascular smooth muscle cell (VSMC) proliferation and migration, two events critical to formation of stenotic vascular lesions. In some systems, elevating adenosine 3′,5′-cyclic monophosphate (cyclic AMP) inhibits TNF-α induced gene transcription. We recently demonstrated that interleukin-6 (IL-6) was chemotactic to VSMC. Therefore, we tested the hypothesis that elevating cyclic AMP would inhibit TNF-α-mediated IL-6 expression and VSMC migration. Materials and methods. VSMC were cultured from saphenous vein remaining after coronary artery bypass grafting. Migration of VSMC through a porous membrane was determined. Intracellular cyclic AMP was elevated by exposing the cells to forskolin or 8-Br-cyclic AMP and was measured by radioimmunoassay. IL-6 was measured by enzyme-linked immunosorbent assay. Results. TNF-α induced migration of VSMC in a concentration-dependent manner. Incubation of cells with forskolin significantly increased cyclic AMP. Co-incubation of cells with TNF-α in combination with 8-Br-cyclic AMP or forskolin inhibited migration by approximately 25 and 70%, respectively. Incubation with TNF-α increased release of IL-6 from VSMC 18-fold over basal. This stimulated release was inhibited by either 8-Br-cyclic AMP or forskolin. In cells stimulated with TNF-α, addition of an antibody to IL-6 reduced migration by 25%. Conclusions. These data show that IL-6 produced by VSMC contributes to cell migration induced by TNF-α. Further, elevating cyclic AMP inhibited TNF-α-induced release of IL-6, and migration of VSMC. These results are consistent with the notion that mechanisms that increase intracellular cyclic AMP, such as activation of β-adrenergic receptors on VSMC, act as a brake on cell migration.

AB - Background. Gene expression induced by tumor necrosis factor-α (TNF-α) is involved in the regulation of vascular smooth muscle cell (VSMC) proliferation and migration, two events critical to formation of stenotic vascular lesions. In some systems, elevating adenosine 3′,5′-cyclic monophosphate (cyclic AMP) inhibits TNF-α induced gene transcription. We recently demonstrated that interleukin-6 (IL-6) was chemotactic to VSMC. Therefore, we tested the hypothesis that elevating cyclic AMP would inhibit TNF-α-mediated IL-6 expression and VSMC migration. Materials and methods. VSMC were cultured from saphenous vein remaining after coronary artery bypass grafting. Migration of VSMC through a porous membrane was determined. Intracellular cyclic AMP was elevated by exposing the cells to forskolin or 8-Br-cyclic AMP and was measured by radioimmunoassay. IL-6 was measured by enzyme-linked immunosorbent assay. Results. TNF-α induced migration of VSMC in a concentration-dependent manner. Incubation of cells with forskolin significantly increased cyclic AMP. Co-incubation of cells with TNF-α in combination with 8-Br-cyclic AMP or forskolin inhibited migration by approximately 25 and 70%, respectively. Incubation with TNF-α increased release of IL-6 from VSMC 18-fold over basal. This stimulated release was inhibited by either 8-Br-cyclic AMP or forskolin. In cells stimulated with TNF-α, addition of an antibody to IL-6 reduced migration by 25%. Conclusions. These data show that IL-6 produced by VSMC contributes to cell migration induced by TNF-α. Further, elevating cyclic AMP inhibited TNF-α-induced release of IL-6, and migration of VSMC. These results are consistent with the notion that mechanisms that increase intracellular cyclic AMP, such as activation of β-adrenergic receptors on VSMC, act as a brake on cell migration.

KW - Cyclic AMP

KW - Interleukin-6

KW - Smooth muscle cell migration, tumor necrosis factor-α

UR - http://www.scopus.com/inward/record.url?scp=0037289168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037289168&partnerID=8YFLogxK

U2 - 10.1016/S0022-4804(02)00038-0

DO - 10.1016/S0022-4804(02)00038-0

M3 - Article

VL - 109

SP - 57

EP - 61

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -